CACNB1: A Protein Involved in Neurotransmitter Regulation and Cellular Signaling Pathways

Target Name: CACNB1

NCBI ID: G782

CACNB1

CACNB1: A Protein Involved in Neurotransmitter Regulation and Cellular Signaling Pathways

CACNB1 (CACB1_HUMAN), also known as human CACN-B1, is a protein that is expressed in various tissues of the human body. It is a member of the CACN (cationic amino acid neurotransmitter receptor) family, which is a group of transmembrane proteins that play a crucial role in neurotransmitter signaling.

CACNB1 is primarily localized to the basal ganglia, which is a part of the nervous system that is responsible for the coordination and control of various physiological functions. It is involved in the release and uptake of neurotransmitters, including dopamine, a well-known neurotransmitter that is involved in motor function, mood regulation, and other brain functions.

CACNB1 has been shown to play a crucial role in the regulation of dopamine release and uptake in the basal ganglia. It is known to interact with the neurotransmitter receptor DOP1, which is located in the same family of proteins that includes the dopamine receptor DOP2. This interaction between CACNB1 and DOP1 allows for the regulation of dopamine release and uptake by CACNB1.

In addition to its role in neurotransmitter regulation, CACNB1 is also involved in the regulation of ion channels in the nervous system. It has been shown to interact with the voltage-dependent ion channel K+ channel, which is responsible for the regulation of neuronal excitability. This interaction between CACNB1 and K+ channels allows for the regulation of neuronal excitability and the modulation of neural activity.

CACNB1 is also involved in the regulation of cellular signaling pathways that are critical for brain development and function. It has been shown to play a role in the regulation of neurogenesis, which is the process by which new neurons are generated in the nervous system. Additionally, CACNB1 is involved in the regulation of synaptic plasticity, which is the ability of the nervous system to change and adapt in response to experience.

CACNB1 is a potential drug target for the treatment of various neurological disorders. For example, CACNB1 has been shown to be involved in the regulation of dopamine release and uptake in the basal ganglia, which is implicated in the treatment of symptoms of Parkinson's disease, such as tremors and rigidity. Additionally, CACNB1 has been shown to play a role in the regulation of neuronal excitability and the modulation of neural activity, which is implicated in the treatment of various psychiatric disorders, such as depression and anxiety.

In conclusion, CACNB1 is a protein that is involved in the regulation of various physiological functions in the human body. Its role in neurotransmitter regulation, ion channel regulation, and cellular signaling pathways is crucial for brain development and function. As a potential drug target, CACNB1 is a promising target for the treatment of various neurological disorders. Further research is needed to fully understand the role of CACNB1 in neural function and the potential benefits of its targeted therapy.

Protein Name: Calcium Voltage-gated Channel Auxiliary Subunit Beta 1

Functions: Regulatory subunit of L-type calcium channels (PubMed:1309651, PubMed:8107964, PubMed:15615847). Regulates the activity of L-type calcium channels that contain CACNA1A as pore-forming subunit (By similarity). Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit and increases the presence of the channel complex at the cell membrane (PubMed:15615847). Required for functional expression L-type calcium channels that contain CACNA1D as pore-forming subunit (PubMed:1309651). Regulates the activity of L-type calcium channels that contain CACNA1B as pore-forming subunit (PubMed:8107964)

The "CACNB1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CACNB1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets